课题基金 / 基金详情

Development of inhalable formulations of anti-fibrotic agents with reduced risk of side effects

Development of inhalable formulations of anti-fibrotic agents with reduced risk of side effects
开发可降低副作用风险的抗纤维化药物吸入制剂
批准号:
15K18928
负责人:
Seto Yoshiki
金额:
$2.58万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Young Scientists (B)
财政年份:
2015
资助国家:
日本
项目状态:
已结题
起止时间:
2015-04-01 至 2018-03-31

项目摘要

项目成果

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
期刊论文(16)
专著(0)
科研奖励(0)
会议论文
Development of an improved inhalable powder formulation of pirfenidone by spray-drying: in vitro characterization and pharmacokinetic profiling
通过喷雾干燥开发改进的吡非尼酮吸入粉末制剂:体外表征和药代动力学分析
DOI: 10.1007/s11095-016-1887-3
发表时间: 2016
期刊: Pharmaceutical Research
影响因子: 3.7
作者: [2)Yoshiki Seto, Gen Suzuki, Sharon Shui Yee Leung, Hak-Kim Chan, Satomi Onoue]
通讯作者: Satomi Onoue
DOI: 10.1016/j.dmpk.2017.06.001
发表时间: 2017-10-01
期刊: DRUG METABOLISM AND PHARMACOKINETICS
影响因子: 2.1
作者: [Kojo, Yoshiki, Kobayashi, Kanako, Onoue, Satomi]
通讯作者: Onoue, Satomi
Enhanced pharmacokinetic behavior and hepatoprotective function of ginger extract-loaded supersaturable self-emulsifying drug delivery systems
生姜提取物负载的过饱和自乳化给药系统增强的药代动力学行为和保肝功能
DOI: 10.1016/j.jff.2017.08.035
发表时间: 2018
期刊: Journal of Functional Foods
影响因子: 5.6
作者: [Ogino Mizuki, Yakushiji Keisuke, Suzuki Hiroki, Shiokawa Kenichi, Kikuchi Hiroshi, Seto Yoshiki, Sato Hideyuki, Onoue Satomi]
通讯作者: Onoue Satomi
Enzymatic reactive oxygen species assay to evaluate phototoxic risk of metabolites
酶法活性氧测定法评估代谢物的光毒性风险
DOI: 10.1016/j.toxlet.2017.07.852
发表时间: 2017
期刊: Toxicol Lett
影响因子: 3.5
作者: [Kato M, Ohtake H, Sato H, Seto Y, Onoue S]
通讯作者: Onoue S
12